Can we afford to forget the old killer (tuberculosis) in this COVID-19 pandemic: a case report of scrofula with COVID-19 in a health care worker

Authors

  • Roshan Lal Department of Medicine, SLBSGMCH Mandi, Nerchowk, Himachal Pradesh, India
  • Rajesh Bhawani Department of Medicine, SLBSGMCH Mandi, Nerchowk, Himachal Pradesh, India
  • Nitesh Kumar Department of Medicine, SLBSGMCH Mandi, Nerchowk, Himachal Pradesh, India
  • Jyoti Bala Department of Pathology, SLBSGMCH Mandi, Nerchowk, Himachal Pradesh, India
  • Sharab Chhopal Department of Pathology, SLBSGMCH Mandi, Nerchowk, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20210897

Keywords:

Scrofula, Extra pulmonary tuberculosis, COVID-19

Abstract

In the current scenario of COVID-19 pandemic, we are encountering COVID-19 patients with vague symptoms and in association with many other diseases. We are reporting such a case where neglecting other cause of pyrexia in a patient of COVID-19 would have resulted in disastrous consequences. A young 22 years aged female was admitted to our hospital as COVID-19 with right supraclavicular lymphadenopathy, she was subjected to FNAC of right supraclavicular lymph node. In RT-PCR Mycobacterium Tuberculosis was detected. After three days of starting on Antitubercular drugs she became afebrile. It is important to ensure early diagnosis and continuity of services for tuberculosis along with effective and rapid response to COVID-19 pandemic, so that anticipated increase in TB related deaths during this pandemic can be prevented.

References

David J Cennimo.Coronavirus Disease 2019 (COVID-19). Medscape. 2020.

Lewis MR. Scrofula Overview of Scrofula Drugs & Diseases > Otolaryngology and Facial Plastic Surgery. Updated: 10 May 2019.

Zhu N, Zhang D, Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.

Doremalen VN, Bushmaker T, Morris DH. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-7.

World Health Organization. Novel coronavirus (2019-nCoV) situation report - 6. 2020.

Liu Z, Bing X, Zhi XZ. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. 2020;41(2):145-51.

Madhukar Pai. COVID-19 Coronavirus and Tuberculosis: We Need A Damage Control Plan. Forbes. 2020.

Scrofula CJ. Available at: www.emedicine.com/ent/topic524.htm. Accessed on 20 September 2008.

World Health Organisation. World Health Organization (WHO) Information Note Tuberculosis and COVID-19 on 11 May 2020.

Downloads

Published

2021-02-25

How to Cite

Lal, R., Bhawani, R., Kumar, N., Bala, J., & Chhopal, S. (2021). Can we afford to forget the old killer (tuberculosis) in this COVID-19 pandemic: a case report of scrofula with COVID-19 in a health care worker. International Journal of Research in Medical Sciences, 9(3), 891–894. https://doi.org/10.18203/2320-6012.ijrms20210897

Issue

Section

Case Reports